Beta-hCG + Erythropoietin in Acute Stroke "BETAS"

Completed

Phase 2 Results

Summary of Purpose

The purpose of this study is to assess the safety of Beta-hCG + Erythropoietin in patients with acute ischemic stroke.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 16 August 2016.

1 Aug 2006 9 Aug 2006 1 Mar 2008 1 Mar 2008 1 Aug 2016 12 Jun 2012
Start Date First Received 1st Completion Completion Verification Results

Trial Design

  • Allocation: Non-Randomized
  • Masking: Open Label
  • Purpose: Treatment
  • Endpoint: Safety Study
  • Intervention: Single Group Assignment

Contacts

  • Steven C. Cramer, MD, MMSc 714 456-6876

    scramer@uci.edu